Boothbay Fund Management, LLC Chroma Dex Corp. Transaction History

Boothbay Fund Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.28 - $1.6 $12,956 - $16,195	10,122 Added 7.29%	149,035 $213,000
Q3 2023 Nov 14, 2023	BUY	$1.36 - $1.77 $188,921 - $245,876	138,913 New	138,913 $202,000
Q2 2019 Aug 14, 2019	SELL	$3.71 - $4.83 $117,154 - $152,521	-31,578 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$3.2 - $4.19 $44,985 - $58,903	14,058 Added 80.24%	31,578 $132,000
Q4 2018 Feb 14, 2019	BUY	$2.8 - $4.22 $49,056 - $73,934	17,520 New	17,520 $60,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $360M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.